Replies to post #375755 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

The firm was the one who valued us at a "Most Likely" valuation of $2.10.

They wrote Elite a 30-page report detailing every faucet of the company at the time and why we should be valued at a "Most Likely" $2.10.

Here is the FULL quote from Carter Ward:

"We engaged the prominent consulting firm in the field of company and stock price valuation. These are consultants who are viewed as authorities on the subject. They have written the leading textbooks on the subject and they worked regularly with the investment community.

They conducted a thorough study with lengthy interviews and due diligence. And then they finally issued a 30 page report which confirmed our opinion. The report shows a conservative valuation, a most likely valuation and a best case valuation. And I can tell you the conservative valuation was $0.40, most likely was $2.10 and the best case valuation was $2.75, all of these on a fully diluted basis.

So that’s $0.40, $2.10 and $2.75 and that’s not future value, that’s the present value today. Future value will be more. Now these valuations are based on the Elite executing its’ strategic plan and we’re on schedule as you can tell by our financials."


-----------------------------------------------------------------------------------------------------------------------------------